Introduction
A number of gene products have been implicated in the control of the balance between cell proliferation and cell death. Aberrant cell survival resulting from the inhibition of cell death would be expected to contribute to oncogenesis (Marx, 1993) . Paradoxically, a number of dominant oncogenes appear to act as potent inducers of apoptosis (Harrington et al., 1994b) . The involvement of these oncogenes, and, more speci®cally, of the c-myc proto-oncogene, in the activation and/or modulation of the apoptotic process has been extensively analysed (El-Deiry, 1997; Harrington et al., 1994b) . The c-myc proto-oncogene is a member of a family of related genes implicated in the control of cell proliferation and its deregulated expression can contribute to neoplasia promotion and/or progression (Spencer and Groudine, 1991) . The c-Myc oncoprotein is a short-lived, sequence-speci®c DNA-binding protein, which acts as a transcription factor in association with its partner, Max (Amati and Land, 1994) . In normal cells, c-myc expression is tightly controlled by mitogenic stimuli and appears to be necessary, and in some instances sucient, to promote cell proliferation (reviewed by Evan and Littlewood, 1993) , as well as to suppress dierentiation (reviewed by Homan and Liebermann, 1994) . The observation that disruption of c-Myc function by gene targeting is associated with severe growth impairment and a subsequent lethal phenotype (Davis et al., 1993) con®rms the essential role of this proto-oncogene in the regulation of cell proliferation. However, under some circumstances, cMyc can also act as a potent inducer of apoptosis. cMyc-induced apoptosis has been reported in cells deprived of speci®c growth factors (Askew et al., 1991) , in serum-starved cells, in cells growth-arrested by drug administration and in cells cultured under hypoxic conditions (Alarcon et al., 1996; Rupnow et al., 1998) .
The programmed cell death process induced by cMyc can be inhibited either by activation of an antiapoptotic signal transduction pathway triggered by speci®c survival factors (Harrington et al., 1994a) or by the deregulated expression of genes such as those of the bcl-2 family (Reed, 1995 (Reed, , 1997 . Bcl-2 cooperates with c-myc to immortalize pre-B cells (Vaux et al., 1988) and its product prevents apoptotic cell death induced by c-Myc (Bissonnette et al., 1992; Fanidi et al., 1992; Wagner et al., 1993) . It has been demonstrated that Bcl-2 functions upstream of the caspase-3/ CPP32 enzyme (Chinnaiyan et al., 1996) , a cysteine protease which is responsible for poly(ADP-ribose) polymerase proteolysis (Lazebnik et al., 1994) and which has been recently reported to play a critical role in c-Myc-mediated apoptosis (Kangas et al., 1998) .
The expression of the c-myc proto-oncogene is frequently deregulated in human tumors; translocations and ampli®cations of the gene as well as increased half-life and overexpression of the oncoprotein have been observed in many tumors (Bishop, 1995; Brison, 1993; Marcu et al., 1992) . Although it is well established that apoptosis can be induced by the enforced expression of exogenously introduced c-myc genes in several experimental systems, it is still not clear whether overexpression of the resident c-myc gene owing to its ampli®cation in tumor cells is sucient to induce apoptosis (Packham and Cleveland, 1995) . To investigate the hypothesis that deregulated c-myc expression resulting from ampli®cation of the gene could promote apoptosis, we examined the eect of growth-restrictive conditions on the rate and the extent of cell death in cell lines characterized by dierent cmyc ampli®cation levels. We performed our analysis on tumorigenic and non-tumorigenic clones isolated from the SW613-S human colon carcinoma cell line. Cells of the tumorigenic clones have a high level of amplification of the c-myc gene, whereas cells of the nontumorigenic clones have a small number of copies of this gene (Lavialle et al., 1988 (Lavialle et al., , 1990 (Lavialle et al., , 1989 . We report here that cells of tumorigenic and non-tumorigenic clones respond dierently to growth-restrictive conditions resulting from serum starvation, the former being apoptosis-prone and the latter apoptosis-resistant. Moreover, we showed that introduction of multiple copies of a plasmid bearing a complete human c-myc gene into the cells of apoptosis-resistant, non-tumorigenic clones confers on them the apoptosis-prone phenotype. Altogether, these results strongly support the idea that a high expression level of the c-myc gene, resulting from gene ampli®cation, contributes to the apoptosis-prone phenotype of these colon carcinoma cells.
Results
Human colon carcinoma cells with a high level ampli®cation of the c-myc gene are susceptible to apoptotic cell death induced by serum deprivation
To investigate the hypothesis that c-myc overexpression resulting from the ampli®cation of the gene could promote apoptosis, we used cells of tumorigenic and non-tumorigenic clones derived from the SW613-S human colon carcinoma cell line. It was previously shown (Lavialle et al., 1988 (Lavialle et al., , 1990 (Lavialle et al., , 1989 Modjtahedi et al., 1985) that the SW613-S cell line is mainly composed of two cell types: (i) cells with a high level of ampli®cation and expression of the c-myc gene and tumorigenic in nude mice; (ii) cells which harbor a small number of copies of this gene, resulting in a lower expression level, and which are non-tumorigenic in mice. Several clones representative of each of these two cell types have been isolated (i.e. tumorigenic clones SW613-12A1, -3, -4A and non-tumorigenic clones SW613-B3, -2G1, -4G).
Since it has been demonstrated that enforced expression of exogenously introduced c-myc genes sensitizes cells to apoptosis induced by growth-factor withdrawal Hueber et al., 1997) , we examined the eect of serum-deprivation on dierent tumorigenic and non-tumorigenic clones. As representatives of tumorigenic and non-tumorigenic clones, the SW613-12A1 and SW613-B3 cell lines have been analysed. Nuclei of cells incubated for 72 h in a medium containing 0.1% serum were stained with Hoechst 33258 and observed by¯uorescence microscopy. As illustrated in Figure 1A , serum-starved 12A1 cells showed nuclear morphological changes typical of apoptotis such as chromatin condensation and fragmentation (c'), whereas B3 cells exhibited a normal nuclear morphology (c), under the same experimental conditions. The fraction of cells with condensed or fragmented nuclei was about 60% for clone 12A1 versus 1.5% for clone B3 after 72 h of serum deprivation.
In parallel with the¯uorescence microscopic observations,¯ow cytometric analysis was carried out, using DNA content as a single parameter. The results are shown in Figure 1B and the quantitative analysis of cell cycle distribution is summarized in Figure 1C . 12A1 and B3 cells have comparable growth rates (doubling times 27 and 24 h, respectively; data not shown) and similar cell cycle distributions when grown in the presence of 10% serum (compare a' to a). After 24 h of serum depletion, a marked reduction in the fraction of cells in S phase and an accumulation of cells in the G 1 phase were observed for both cell lines. Remarkably, a subdiploid cell population (A 0 ) appeared in 12A1 cells incubated for 24 h in the presence of 0.1% serum, whereas such a subpopulation was not detectable in B3 cells, under the same conditions ( Figure 1B , panels b' and b). The presence of this population is indicative of cell death and is often considered as a marker of apoptosis (Darzynkiewicz et al., 1992) . Prolonged incubation (72 h) in the presence of 0.1% serum resulted in a signi®cant increase in the fraction of the subdiploid cell population in 12A1, but not in B3 cells (compare c' to c). By that time, it represented about 60% of the whole 12A1 cell population ( Figure 1C ), thus con®rming the data obtained by microscopic observation. Both cell lines were also tested for their capability to respond to serum addition following growth-factor withdrawal. Cell cycle distribution was analysed for cells ®rst starved during 72 h and then stimulated to grow by the addition of 10% serum (d' and d) . Cells of both cell lines resumed DNA synthesis, as evidenced by an increase in the fraction of S and G 2 /M phase populations. However, most of the 12A1 cells from the A 0 population could not reenter the cell cycle, con®rming the occurrence of cell death.
As chromatin fragmentation by internucleosomal DNA cleavage is considered a hallmark of apoptosis, the appearance of a DNA ladder was investigated by agarose gel electrophoresis of genomic DNA extracted from serum-starved 12A1 and B3 cells (Figure 2A ). An incubation period of 24 h in 0.1% serum-containing medium was sucient to induce internucleosomal DNA degradation in 12A1 cells. Nucleosomal DNA fragments further accumulated in these cells upon prolonged incubation under low serum conditions. In marked contrast, B3 cells did not show any evidence of DNA fragmentation, even after 72 h of incubation in 0.1% serum-containing medium. As expected, supplying the medium with 10% serum did not result in the reversion of the degradation process in apoptotic 12A1 cells.
Another marker of apoptosis is the proteolytic cleavage of the 116 kDa poly(ADP-ribose) polymerase c-myc amplification and propensity to apoptosis M Donzelli et al (PARP) into two fragments of 85 and 29 kDa by the caspase-3/CPP32 cysteine protease (Lazebnik et al., 1994) . Therefore, we analysed the status of the PARP protein in 12A1 and B3 starved cells. Western blotting experiments revealed that the 116 kDa protein was the only form present in exponentially growing 12A1 and B3 cells ( Figure 2B ; 0 h time point). As a result of PARP cleavage, the 85 kDa proteolytic fragment was generated in 12A1 cells upon serum starvation, while this fragment remained undetectable in B3 cells. In 12A1 cells, the 85 kDa fragment was already evident after only 24 h of incubation in the presence of 0.1% serum and the full-length protein appeared to be completely cleaved after 48 h, as judged from the disappearance of the 116 kDa band. No evidence of PARP proteolysis was observed at any time point in serum-starved B3 cells. Apoptosis induced by serum starvation in tumorigenic 12A1 cells was therefore associated with caspase(s) activation leading to PARP cleavage, as already described for apoptosis induced by enforced c-myc expression (Kangas et al., 1998) . Taken together, these results demonstrate that serum starvation causes tumorigenic cells to die by apoptosis, whereas non-tumorigenic cells are fully resistant to apoptosis induction.
Regulation of c-myc gene expression in serum-starved 12A1 and B3 cells
It has been previously shown that tumorigenic and non-tumorigenic clones of the SW613-S cell line are characterized by dierent levels of ampli®cation of the c-myc gene and that a high level of ampli®cation contributes to the tumorigenic phenotype (Lavialle et al., 1988; Modjtahedi et al., 1985) . To evaluate the expression level of c-myc in serum-deprived B3 and 12A1 cells, we analysed total cytoplasmic RNA by Northern blotting with a c-myc probe ( Figure 3A ). Cells were incubated in the presence of 0.1% serum over a period of 72 h and then allowed to recover for c-myc amplification and propensity to apoptosis M Donzelli et al 24 h in medium supplemented with 10% serum. Cytoplasmic RNA was extracted at various time points during both incubation periods. RNA loading and transfer was monitored using a probe for the 28S rRNA. The level of c-myc mRNA was quanti®ed by densitometric analysis and the data, normalized to the 28S RNA signal, are shown in Figure 3B . The steadystate level of c-myc mRNAs was about sixfold higher in exponentially growing 12A1 cells than in B3 cells (0 h time point), as previously reported (Lavialle et al., 1988) . This is the consequence of the dierence in cmyc ampli®cation level between the two cell types. After 24 h of serum starvation, both cell lines exhibited a decrease in the level of c-myc mRNAs which fell in both cases to about 50% of the level found in the corresponding growing cells. This resulted in a very low level in B3 cells, but in 12A1 cells the level of cmyc mRNAs was still 2.5 times higher than that in proliferating B3 cells. Since a large fraction of 12A1 cells were dying (see above) and since c-myc mRNAs have a very short half-life (much shorter than that of ribosomal RNA), this ®gure was probably even higher in still alive 12A1 cells. In restimulated cells, the kinetics of c-myc mRNA accumulation was analysed over a period of 24 h ( Figure 3 ). One hour after serum addition, both cell lines showed an increase in c-myc expression. Nevertheless, B3 cells appeared to be more reactive than 12A1 cells since, after 2.5 h of incubation in the presence of 10% serum, the level of c-myc mRNAs was transiently increased about eightfold above the level found in starved B3 cells, whereas, under the same experimental conditions, the increase was less than twofold in 12A1 cells. After 24 h of serum stimulation, the level of c-myc mRNAs returned to control level in B3 cells. For 12A1 cells, it was lower than in exponentially growing cells, probably because in a large fraction of apoptotic cells the unstable c-myc mRNAs were degraded at the time of analysis, but not ribosomal RNA. Altogether, these results indicate that the expression of the c-myc gene is tightly regulated by serum growth factors in B3 cells, whereas it is poorly regulated in 12A1 cells, the level of their mRNAs remaining quite high in starved cells. As analysed by Western blotting, the high level of c-myc mRNAs After 72 h of incubation in low serum medium, cells were restimulated by the addition of 10% serum containing-medium and collected at the indicated times (1, 2.5, 4 and 24 h). Nucleosomal DNA fragments were resolved by electrophoresis in a 1.8% agarose gel and visualized by ethidium bromide staining. M: 100 Base-Pair Ladder. (B) Total cellular extracts were prepared from 12A1 and B3 cells collected before starvation (0 h) and after 24, 48, 72 or 96 h of incubation in medium containing 0.1% serum. PARP speci®c cleavage was analysed by Western blotting using monoclonal antibody C-2-10 which recognizes both the full-length enzyme (116 kDa) and the 85 kDa proteolytic fragment (arrowheads) Figure 3 Analysis of c-myc expression in serum-starved cells. B3 and 12A1 cells were collected before starvation (0 h) and after 24, 48 or 72 h of incubation in medium containing 0.1% serum. After 72 h of starvation, cells were refed with medium containing 10% serum and collected at dierent times (1, 2.5, 4 or 24 h). (A) For each experimental time point cytoplasmic RNA was extracted and 10 mg aliquots were analysed by Northern blotting with a c-myc probe. The membrane was subsequently incubated with a 28S rRNA oligonucleotidic probe for controlling RNA loading and transfer. (B) Hybridization signals were quanti®ed (see Materials and methods) and normalized to the corresponding 28S rRNA signal. The levels of c-myc mRNA are expressed as arbitrary units. (C) For each experimental time point total cellular extracts were obtained and 30 ml aliquots were analysed by Western blotting with the monoclonal antibody 9E10 directed against the c-Myc protein c-myc amplification and propensity to apoptosis M Donzelli et al observed in 12A1 cells resulted in a high protein level which was not modulated during serum-starvation ( Figure 3C ). On the contrary, c-Myc was undetectable even in exponentially growing B3 cells (data not shown). The high level of c-myc expression resulting from this poor regulation might contribute to the apoptosis-prone phenotype of cells from tumorigenic clones.
Transfection with an exogenous c-myc gene confers an apoptosis-prone phenotype on cells of non-tumorigenic clones
To demonstrate that c-myc ampli®cation and, consequently, a high expression level of the gene contributes to the apoptosis-prone phenotype of tumorigenic clones, we analysed the behavior of two cell lines (B3mycC5 and 2G1mycP2Tu1) that have been derived from non-tumorigenic clones by transfection with an exogenous human c-myc gene and which express the proto-oncogene at dierent levels. B3mycC5 is a clone isolated in vitro after transfecting B3 cells with a plasmid containing a complete human c-myc gene (Modjtahedi et al., 1992) . 2G1mycP2Tu1 is a cell line established from a tumor induced in a nude mouse by injection of a pool of clones obtained by transfecting cells of the non-tumorigenic clone SW613-2G1 with a plasmid containing the entire human c-myc gene (Lavialle et al., 1988) . Cells of the non-tumorigenic 2G1 clone have properties identical to those of the B3 clone, namely a low level of ampli®cation and expression of c-myc and a resistant-phenotype to the induction of apoptosis by serum deprivation (data not shown). Both transfected cell lines have acquired the tumorigenic phenotype (Lavialle et al., 1988) and express the exogenous c-myc gene at dierent levels ( Figure 4 ). B3mycC5 cells showed an intermediate level of expression of the oncogene with respect to B3 and 12A1, whereas 2G1mycP2Tu1 cells exhibited a level of expression higher than that observed in 12A1 cells. Cells of both transfected cell lines were incubated in the presence of 0.1% serum for 72 h and analysed for apoptotic morphological changes. Hoechst staining revealed typical apoptotic features in both cell lines, such as nuclear condensation and chromatin fragmentation ( Figure 5 ). The apoptotic index for B3mycC5 and 2G1mycP2Tu1 cells was about 12 and 70%, respectively. When compared to the ®gures obtained for B3 and 12A1 cells (1.5% and 60%, respectively), these values established a correlation between the level of c-myc gene expression and the propensity to undergo apoptosis. These results were con®rmed by cell cycle distribution analysis which disclosed that serum deprivation induced the appearance of a subdiploid population in both transfected cell lines ( Figure 5 ). The fraction of cells with hypodiploid DNA content in B3mycC5 and 2G1mycP2Tu1 cell populations that have been serum-starved for 72 h was consistent with the apoptotic index evaluated by Hoechst staining.
Analysis of genomic DNA by agarose gel electrophoresis con®rmed the above observations (Figure 6) . A DNA ladder re¯ecting chromatin fragmentation into nucleosomes was already visible in the 2G1mycP2Tu1 DNA sample from cells harvested after 24 h of serum starvation. This phenomenon occurred only later on in B3mycC5 cells (at 72 or 96 h), con®rming that the extent of apoptosis correlates with the level of c-myc expression. The integrity of genomic DNA was also analysed in serum-starved cells from three clones isolated after transfection of B3 cells with a control plasmid conferring neomycin resistance but devoid of the c-myc gene (B3neoB5, B3neoA7, B3neoA8) and from a B3-derived c-myc transfectant (B3mycD4) expressing the c-myc gene at a lower level than B3mycC5 cells. No evidence of apoptosis in any of these cell lines could be obtained (data not shown).
p53 gene status in cells of tumorigenic and nontumorigenic clones
The p53 gene is frequently inactivated in tumor cells (Levine, 1993) , including the SW613-S-related cell line SW480 (Nigro et al., 1989; Lavialle et al., 1990) . Wildtype p53 protein reintroduced into cells harboring (Haupt et al., 1995; Lowe et al., 1993; Shaw et al., 1992; Yonish-Rouach et al., 1991) . A role for the p53 protein in c-Myc-induced apoptosis has been examined. Activation of the c-myc gene results in a rapid accumulation of the p53 protein (Hermeking and Eick, 1994) , suggesting that p53 may be important in mediating c-myc-induced apoptosis (Han et al., 1997; Wagner et al., 1994) . However, it has been recently reported that c-myc-induced apoptosis might as well occur via p53-independent mechanisms (Fukasawa et al., 1997; Sakamuro et al., 1995) . We have therefore analysed the status of the p53 gene in cells of the 12A1 and B3 clones. DGGE analysis of exons 5 ± 8 revealed the presence of a mutation in exon 8 in both cell lines (data not shown). Sequence determination indicated that both cell lines bear the same CGT to CAT transition at codon 273, resulting in an His for Arg aminoacid substitution (data not shown). This same p53 mutation has been previously found in the SW480 cell line; the mutation is located within the DNA binding domain of the p53 protein and results in its inactivation (Nigro et al., 1989) . The presence of this inactive form of the protein excludes a role for p53 in the mechanism of c-Myc-induced apoptosis in 12A1 cells.
Discussion
Many studies have indicated that enforced expression of an exogenously introduced c-myc gene leads to cell death by apoptosis in several cell systems. For example, a role for c-myc as an inducer of apoptosis has been shown in serum-starved primary or immortalized ®broblasts Fanidi et al., 1992; Hueber et al., 1997) or in IL-3-dependent myeloid cells upon withdrawal of the cytokine (Askew et al., 1991) and this role was more recently con®rmed by in vivo studies (Alarcon et al., 1996; Rupnow et al., 1998) . Furthermore, an involvement of the c-myc gene in receptor-mediated and chemotherapy-induced apoptosis has been recently reported by Dong et al. (1997) . However, it was not clear whether overexpression of the resident c-myc gene resulting from its ampli®cation in tumor cells is sucient to induce apoptosis (Packham and Cleveland, 1995) . In this study we have tested the hypothesis that c-myc ampli®cation could sensitize tumor cells to apoptosis. We used tumorigenic and non-tumorigenic clones derived from the SW613-S human colon carcinoma cell line. These clones are characterized by dierent levels of c-myc ampli®cation and expression. Cells of tumorigenic clones overexpress the c-myc gene as a consequence of its ampli®cation to a high level, whereas cells of non-tumorigenic clones have a low level of amplification and expression of the proto-oncogene. In this work we have shown that cells of the SW613-12A1 clone, a representative of tumorigenic clones, are susceptible to cell death under low serum culture conditions. In contrast, cells of the SW613-B3 clone, a representative of non-tumorigenic clones, are resistant to serum deprivation. Dying 12A1 cells showed chromatin condensation, internucleosomal DNA degradation and proteolysis of the PARP protein, whereas these symptoms were never observed in B3 cells. These observations suggested that expression of c-myc to a high level as a result of gene ampli®cation might contribute to the apoptosis-prone phenotype of 12A1 cells. We have shown that in B3 cells c-myc expression was down-regulated in response to serum deprivation and that subsequent addition of serum to starved cells led, within 2.5 h, to a transient eightfold increase in the level of c-myc mRNAs. These results indicate that in these cells c-myc expression is tightly regulated by serum growth factors, as already described for many other cell types (Evan and Littlewood, 1993; Spencer and Groudine, 1991) . In serum-starved 12A1 cells, the level of c-myc mRNAs decreased, but the contribution of a downregulation of the expression was uncertain since a large fraction of the cells was committed to die. Notwithstanding, the level of c-myc mRNAs in starved 12A1 cells remained higher than in exponentially growing B3 cells. In addition, c-myc expression in 12A1 cells was stimulated not more than twofold after serum addition. Altogether, these results suggest that, because of the high copy number of the gene, tumorigenic cells are unable to eciently down-regulate the expression of c-myc in response to serum deprivation in order to bring the steady-state level of the mRNA below a critical threshold value, that would allow them to escape apoptotic cell death.
To support this hypothesis, we investigated whether serum starvation could induce apoptosis in cells of stable cell lines (B3mycC5 and 2G1mycP2Tu1) obtained after transfection of two non-tumorigenic clones (SW613-B3 and SW613-2G1) with a c-myccontaining plasmid. We have shown that, in both cases, the cells have acquired an apoptosis-prone phenotype and that, interestingly, the extent of apoptosis was in correlation with the level of c-myc expression. Highlevel c-myc expression in 2G1mycP2Tu1 cells correlated with a massive induction of apoptosis upon serum deprivation and even the moderate increase in cmyc expression in B3mycC5 cells was apparently sucient to trigger apoptosis in serum-starved cells.
The tumorigenicity and the propensity to apoptosis of SW613-S cells which overexpress the resident c-myc gene due to its ampli®cation are apparently in contradiction. This paradoxical dual role of c-myc as an inducer of both neoplastic tranformation and apoptosis can be explained by the`two signal' model ®rst proposed by Bissonnette et al. (1992) and further elaborated by Evan and Littlewood (1993) . According to this model, cells with deregulated c-myc genes are primed for both proliferation and apoptosis, as a normal obligate function of the proto-oncogene. In order to escape apoptosis and to proliferate, the cells require a second signal which can be triggered by speci®c survival factors (Harrington et al., 1994a,b) or by the expression of anti-apoptotic genes such as bcl-2 (Bissonnette et al., 1992; Fanidi et al., 1992; Reed, 1997; Wagner et al., 1993) . If the`two signal' model applies to SW613-S tumorigenic cells, one has to assume that a survival factor, essential for these cells, is lacking when they are serum-starved. Harrington et al. (1994a) demonstrated that some cytokines, including the IGFs and PDGF, may act as survival factors and block c-myc-induced apoptosis. Previous work on tumorigenic and non-tumorigenic SW613-S-derived clones proved that 12A1 cells overexpress the genes of several growth factors, including PDGF-A and IGF-2, as compared to B3 cells (Galdemard et al., 1995; Lamonerie et al., 1995; Lavialle et al., 1989; Modjtahedi et al., 1992) . In addition, it was shown that tumorigenic 12A1 cells can proliferate in a chemically de®ned, serum-free medium containing only transferrin as a proteinaceous component, whereas non-tumorigenic B3 cells cannot. Moreover, we have previously reported that IGF-2 acts through an autocrine pathway that is essential for the growth of tumorigenic cells under these serum-free culture conditions (Lamonerie et al., 1995) . Since tumorigenic cells cannot grow in de®ned medium devoid of transferrin and since none of the growth factors overproduced by tumorigenic cells is apparently sucient by itself to suppress c-myc-induced apoptosis in the absence of transferrin, we conclude that transferrin is a likely candidate as a survival factor for these cells.
A role for the p53 protein in c-Myc-induced apoptosis has been suggested (Han et al., 1997; Hermeking and Eick, 1994; Sakamuro et al., 1995; Wagner et al., 1994) . Our analysis of the p53 gene status in 12A1 and B3 cells indicated that a point mutation at codon 273 is present in both cell lines. The SW480 cell line, which has been derived from the same patient tumor as SW613-S (Lavialle et al., 1990) , bears the same mutation. The presence of this mutated form of the p53 protein, which is not functional (Nigro et al., 1989) , rules out a role for p53 in the mechanism of c-mycinduced apoptosis in tumorigenic SW613-S cells. In keeping with these observations, it has been previously shown that loss of wild-type p53 in colorectal tumor cell lines does not aect sodium butyrate-or radiationinduced apoptosis (Bracey et al., 1995; Hague et al., 1993) . Altogether these observations lead us to consider that the response of colon cancer cells to growthrestrictive conditions might involve a c-myc-dependent, but p53-independent pathway. This would be at variance with the situation described in colon adenoma (premalignant) cells in which the apoptotic response to serum starvation is apparently both c-myc-and p53-independent (Hague et al., 1997) .
The molecular mechanisms by which c-Myc protein(s) triggers apoptosis are still poorly understood (Packham and Cleveland, 1995; Hueber et al., 1997) . Recent evidences have suggested that c-Mycinduced apoptosis requires cell-surface interaction c-myc amplification and propensity to apoptosis M Donzelli et al between the CD95/Fas receptor and its ligand (Hueber et al., 1997) . Preliminary results obtained by¯ow cytometric analysis have indicated that neither CD95 nor its ligand can be detected at the surface of 12A1 cells (unpublished data). This observation suggests that c-Myc-induced apoptosis in cells of tumorigenic SW613-S clones does not involve the CD95 pathway.
Our ®nding of an apoptosis-prone phenotype for SW613-S cells with a high level of ampli®cation of cmyc is apparently discordant with the observation that c-myc ampli®cation occurs quite frequently in human carcinoma cells (Brison, 1993) and should thus confer on them a growth advantage. A high level of ampli®cation also confers on SW613-S cells a tumorigenic phenotype in nude mice, i.e. a growth advantage in vivo. It is therefore possible that apoptosis proneness is a tolerable`price to pay' by the cell to bene®t from this growth advantage, or that, in vivo, other survival factors may exert their anti-apoptotic activity in case of serum factor shortage.
It is known that colon carcinomas are very resistant to drugs commonly used in chemotherapy (Endicott and Ling, 1989) and that a high level of ampli®cation of c-myc is rare in these tumors (Erisman et al., 1985) . Actually, a recent report indicates that a fraction of colon carcinomas is characterized by c-myc gene ampli®cation (mainly at a low level) and that this may predispose patients to a better response to treatment (Augenlicht et al., 1997) . One may wonder whether the propensity of tumor cells with a high level of ampli®cation of c-myc to engage in an apoptotic response could play a role in the induction of apoptosis by antitumoral drugs. Would the rare class of colon tumors with a high level ampli®cation of c-myc be paradoxically more sensitive to chemotherapeutic treatment?
Materials and methods

Cell lines
The origin of the SW613-S cell line, which was derived from a human colon carcinoma, has been previously described (Lavialle et al., 1988 (Lavialle et al., , 1990 (Lavialle et al., , 1989 Modjtahedi et al., 1985) . SW613-12A1, SW613-B3 and SW613-2G1 are, respectively, a tumorigenic and two non-tumorigenic clones derived from the parental SW613-S cell line (Lavialle et al., 1988) . As previously described (Modjtahedi et al., 1992) , B3mycC5 and B3mycD4 are clones derived from the nontumorigenic SW613-B3 cell line after transfection with a plasmid containing both the neomycin-resistance gene and the complete human c-myc gene (pSVTKneomyc1). B3neoB5, B3neoA7 and B3neoA8 are clones isolated after transfection of B3 cells with a plasmid conferring neomycin resistance but devoid of the c-myc gene. 2G1mycP2Tu1 was established from a tumor induced in a nude mouse by injection of a pool of neomycin-resistant colonies obtained after transfection of the non-tumorigenic SW613-2G1 cells with the pSVdhfrmyc7 and pSVTKneob plasmids (Lavialle et al., 1988) . The establishment procedure did not involve an in vitro cloning step.
Cell culture
Cells were maintained in DMEM (Gibco ± BRL, UK) supplemented with 10% fetal calf serum (Hyclone, NL), 4 mM glutamine, 2 mM sodium pyruvate, 100 U/ml penicillin and 0.1 mg/ml streptomycin (all from GIBCO).
Cells were grown at 378C in a humidi®ed atmosphere containing 5% CO 2 . Cells were trypsinized when subconuent and seeded in 100-mm Petri dishes at a concentration of 2.5610 5 cells/ml in medium containing 10% serum. Cells were grown in complete medium for up to 48 h, washed twice with DMEM and then cultured in the presence of 0.1% serum for up to 96 h. For restimulation experiments, cells deprived of serum as just described for 72 h, were refed with medium containing 10% serum and further incubated for up to 24 h. For each experimental time point, cells were collected by trypsinization and analysed.
Evaluation of apoptotic index
Cells were resuspended at a concentration of 10 6 /ml in PBS containing 10% serum and 10 5 cells were cytocentrifuged on a microscope slide at 500 r.p.m. for 3 min. Cells were ®xed for 10 min in ice-cold 70% ethanol and washed several times with ice-cold PBS. DNA was then stained for 10 min at room temperature with 0.1 mg/ml Hoechst 33258 (Sigma, USA). Normal and apoptotic cells were counted under¯uorescence microscopic observation using a Leitz Orthoplan microscope equipped with a 506 objective. The apoptotic index was expressed as the percentage of cells with condensed or fragmented nuclei. For each sample, 500 cells were counted. Pictures were obtained using a Kodak Tmax (400 ASA) b/w ®lm.
Cell cycle analysis
For cell cycle distribution analysis, 10 6 cells were resuspended in 1 ml of cold 0.9% NaCl and then ®xed by adding 2 ml of cold ethanol. DNA was stained with propidium iodide as previously reported (Guano et al., 1994) . Ten thousands cells were analysed at each time point. Measurements were carried out with a Coulter Epics XL cytometer (Coulter Co, USA). Quantitative analysis of cell cycle distribution was performed using the software provided with the instrument.
Analysis of DNA fragmentation
Cells were rinsed twice in cold PBS containing 5 mM EDTA. Genomic DNA was extracted from 5610 6 cells as described (Negri et al., 1995) . Brie¯y, cells were resuspended twice in a lysis buer containing 1% Nonidet-P40, 20 mM EDTA and 50 mM Tris-HCl pH 8.0. The recovered supernatants were combined and incubated with 1% SDS and 0.5 mg/ml RNase A at 568C for 2 h and thereafter treated with 1 mg/ml proteinase K at 378C for 4 h. The DNA was precipitated by the addition of 1/10 volume of 7.5 M ammonium acetate and two volumes of ethanol and analysed by agarose gel electrophoresis. DNA was visualized by staining with 1 mg/ml ethidium bromide. One-hundred Base-Pair Ladder from Pharmacia (Sweden) and Molecular Weight Marker VI from Boehringer Mannheim (Germany) were used as size markers.
Western blot analysis
Cells were washed twice with ice-cold PBS and resuspended at the concentration of 5610 6 /ml in a buer containing 62.5 mM Tris-HCl pH 6.8, 4 M urea, 10% glycerol, 2% SDS, 5% b-mercaptoethanol and 0.003% bromophenol blue, as described by Shah et al. (1995) . Cells were then disrupted by sonication on ice, twice for 30 s (60 W). Equal volumes (corresponding to 30 ml) of each sample were incubated for 15 min at 658C before loading on SDS ± polyacrylamide gel. Samples were electrophoresed in a 7.5% (for PARP detection) or in a 12% (for c-Myc detection) SDS ± PAGE minigel and transferred onto a c-myc amplification and propensity to apoptosis M Donzelli et al nitrocellulose ®lter (Biorad, USA) for 3 h at 48C under a constant voltage of 120 V (Towbin et al., 1979) . Before incubation with antibodies, the membrane was saturated overnight with PTN (PBS containing 0.2% Tween-20 and 10% newborn calf serum). To detect PARP protein the membrane was incubated for 3 h with the monoclonal antibody C-2-10 (diluted 1 : 10 000 in PTN), which recognizes an epitope located between the zinc ®ngers and the automodi®cation domains, at the carboxyl-end of the DNA-binding domain of PARP (Lamarre et al., 1988) . The antibody was kindly provided by Dr G Poirier. c-Myc detection was carried out using the 9E10 clone from Santa Cruz (USA) and the incubation was performed as described above. To remove unreacted antibody the membrane was washed several times with PBS containing 0.2% Tween-20. The membrane was then incubated for 2 h in the presence of anti-mouse IgG conjugated to alkaline phosphatase. Visualization of immunoreactive polypeptides was performed using a BCIP/NBT colour development substrate (all products from Promega, USA).
Northern blot analysis
For cytoplasmic RNA isolation, about 2610 7 cells were scraped in growth medium, pelleted by centrifugation, washed twice with PBS and lysed with Nonidet-P40, as described (Modjtahedi et al., 1985) . Nuclei were sedimented by low speed centrifugation, the supernatant extracted with phenol/chloroform and the RNA precipitated under ethanol. Aliquots (10 mg) of RNA were denatured by heating for 10 min at 688C in the presence of 2.2 M formaldehyde and 50% formamide and immediately loaded onto a 1% agarose gel containing 2.2 M formaldehyde (Sambrook et al., 1989) . Electrophoresis was performed at 35 V for 14 h at room temperature. After two 15 min treatments with a solution containing 50 mM NaOH and 10 mM NaCl, the gel was equilibrated with 150 mM ammonium acetate (pH 7.5), stained with 1 mg/ml ethidium bromide, destained, and the RNA was transferred onto a nylon membrane (Hybond-N, Amersham, UK), essentially as described by Dautry et al. (1988) . Hybridization was carried out as previously descrived (Galdemard et al., 1995) . The c-myc probe was prepared from a ClaI ± EcoRI fragment puri®ed from the pMYC-ECl plasmid (Modjtahedi et al., 1985) and labelled by the random priming method in the presence of [a-32 P]-dCTP (3000 Ci/ mmol, Amersham), using the Megaprime DNA Labelling System (Amersham). An oligonucleotide complementary to the human 28S rRNA (nucleotides 4011 ± 4036) was endlabeled with the T4 polynucleotide kinase in the presence of [g-32 P]-ATP (6000 Ci/mmol, Amersham) and hybridization was carried out according to Barbu and Dautry (1989) . To detect the hybridization signal, membranes were exposed to a Fuji Bio-imager plate and densitometric analysis was performed using the MacBas 2.2 Fuji program. The relative c-myc mRNA content was quanti®ed after correction for the small variations in the amount of membrane-bound RNA, as determined by hybridization with the 28S rRNA probe.
PCR ± DGGE analysis and sequencing of p53 gene exons DNA was extracted from B3 and 12A1 cells and regions corresponding to exons 5 ± 8 of the p53 gene were ampli®ed with speci®c GC-clamped ampliprimers. PCR products were analysed by DGGE as previously reported by Renault et al. (1993) . Genomic DNAs from samples showing variant DGGE patterns were ampli®ed using the appropriate primers without GC-clamp and the PCR products were sequenced by the dideoxy procedure, essentially as described by Pellegata et al. (1994) .
Abbreviations BCIP: 5-bromochloro-3-indolyl phosphate; DGGE: denaturing gradient gel electrophoresis; DMEM: Dulbecco's modi®ed Eagle medium; NBT: p-nitrotetrazolium blue; PARP: poly(ADP-ribose) polymerase; PBS: phosphate buered saline; SDS ± PAGE: sodium dodecyl sulphatepolyacrylamide gel electrophoresis.
